Programme

Morning Abstract and Concurrent Sessions

Basic mechanisms of experimental kidney allograft injury

8:00 AM – 9:00 AM Room Cockle Bay 1 Abstract Session

No lectures listed yet.

Ethics and kidney transplantation

8:00 AM – 9:00 AM Room C4.6 Abstract Session

No lectures listed yet.

Advancing islet and stem cell transplantation: Immune modulation, bioengineering, and graft survival

8:00 AM – 9:00 AM Room C4.7 Abstract Session

No lectures listed yet.

Kidney allograft rejection; mechanisms and novel therapeutics

8:00 AM – 9:00 AM Room C3.3 Abstract Session

No lectures listed yet.

Tolerance versus rejection 2

8:00 AM – 9:00 AM Room Cockle Bay 2 Abstract Session

No lectures listed yet.

Insights into old and new therapeutics 2

8:00 AM – 9:00 AM Room C3.4-C3.5 Abstract Session

No lectures listed yet.

Immune tolerance, biomarkers, and chronic allograft injury in liver transplantation

8:00 AM – 9:00 AM Room C4.5 Abstract Session

No lectures listed yet.

Clinical outcomes, perioperative management, and organ utilization in transplantation

9:15 AM – 10:15 AM Room C4.9 Abstract Session

No lectures listed yet.

Beyond static cold storage: Hypothermic machine perfusion in transplantation—from mechanisms to clinical impact

8:00 AM – 9:00 AM Room C4.11 Abstract Session

No lectures listed yet.

HLA, antibodies, and alloimmune risk in transplantation: Kidney-focused insights with cross-organ relevance

8:00 AM – 9:00 AM Room C4.10 Abstract Session

No lectures listed yet.

Pediatric general

8:00 AM – 9:00 AM Room C4.9 Abstract Session

No lectures listed yet.

Metabolic dysfunction and liver transplantation

8:00 AM – 9:00 AM Room C4.1 Concurrent
- Getting the right patients to transplant: Patient selection, pre-transplant evaluation, and organ allocation in MAFLD
  
  Kymberly Watt (US)
- Optimising outcomes in patients with obesity after transplant: lifestyle modification, bariatric surgery or lifelong GLP1 therapy?
  
  Marina Berenguer (ES)

Key components of an ideal high volume transplant program setup: A global surgical perspective

8:00 AM – 9:00 AM Room C3.6 Concurrent
- The European perspective
  
  Jiri Fronek (CZ)
- The Asian perspective
  
  Ashwin Rammohan (IN)
- The Oceania perspective
  
  Henry Pleass (AU)
- Panel discussion
  
  Discussion Period (AU)

Biogen Corporate Breakfast Symposium on Advancements in Antibody-Mediated Rejection and Microvascular Inflammation of Kidney Allograft

8:00 AM – 8:45 AM Room Parkside 1&2 Industry Symposium

Organized by

No lectures listed yet.

Abstract and Concurrent Sessions

ABO-incompatible kidney transplantation and antibody mediated rejection

9:15 AM – 10:15 AM Room Cockle Bay 1 Abstract Session

No lectures listed yet.

Economics, environment and patient experience in kidney transplantation

9:15 AM – 10:15 AM Room C3.3 Abstract Session

No lectures listed yet.

Immunoregulation in transplantation 2

9:15 AM – 10:15 AM Room C3.4-C3.5 Abstract Session

No lectures listed yet.

Ischaemia reperfusion injury

9:15 AM – 10:15 AM Room Cockle Bay 2 Abstract Session

No lectures listed yet.

Post-transplant complications, risk prediction & outcomes

9:15 AM – 10:15 AM Room C4.5 Abstract Session

No lectures listed yet.

Immunosuppression in liver and kidney transplantation

9:15 AM – 10:15 AM Room C4.6 Abstract Session

No lectures listed yet.

Advances in organ preservation, perfusion, and peri-transplant monitoring across liver, kidney, and pancreas transplantation

9:15 AM – 10:15 AM Room C3.6 Abstract Session

No lectures listed yet.

Vascularized tissue engineering and organ-on-chip platforms for transplantation and organ replacement

9:15 AM – 10:15 AM Room C4.11 Abstract Session

No lectures listed yet.

Long-term outcomes and precision surveillance in heart transplantation: Rejection, vasculopathy, and immune monitoring

9:15 AM – 10:15 AM Room C4.7 Abstract Session

No lectures listed yet.

From allorecognition to allocation: Moving toward more individualized kidney transplant matching

9:15 AM – 10:15 AM Room C4.1 Concurrent
- Importance of HLA beyond the A/B/DR
  
  Anat Tambur (US)
- Beyond HLA: Expanding the immunologic landscape
  
  Toby Coates (AU)
- Precision risk stratification
  
  Wai Lim (AU)

Transplantation beyond traditional publications

9:15 AM – 10:15 AM Room C4.10 Concurrent
Moderators: Stefan Tullius (US), Macey L. Levan (US)
- Special features: A reality check on opportunities and challenges
  
  Fadi Issa (GB)
- Social media: Are we reaching our audience and readership worldwide
  
  Jasper Iske (DE)
- Editorial fellowships: A great opportunity to be involved
  
  Melanie Wyld (AU)
- Topic highlights – Article series
  
  Camille N. Kotton (US)
- Panel discussion
  
  Discussion Period (AU)
- Panelist
  
  Khushboo Saxena (IN)

Coffee Break / Last chance to visit Exhibit Area

Coffee Break

10:15 AM – 10:45 AM Room Hall 1-2 Coffee Break

No lectures listed yet.

Plenary and Concurrent Sessions / TTS Business Meeting

Plenary Session 3

10:45 AM – 12:00 PM Room Darling Harbour Plenary Session
- Towards transplantable organs: Vascularized kidney organoids for renal regeneration
  
  Ton J. Rabelink (NL)
- ABO beyond landsteiner: The next chapter in transplant histocompatibility
  
  Lori J. West (CA)

Expanding horizons in pancreas transplantation: Outcomes, techniques, and program development

10:45 AM – 12:00 PM Room C4.9 Concurrent
Moderators: Pablo Uva (AR), Toby Coates (AU)
- Current status of pancreas transplantation: Activity and outcomes around the world
  
  Angelika C. Gruessner (US)
- Donation after circulatory death (DCD) in pancreas transplantation: Logistics, use of normothermic regional perfusion (NRP) and outcomes
  
  Joana Ferrer (ES)
- Future of pancreas transplantation in the landscape of emerging therapies
  
  Raja Kandaswamy (US)

CMV and BK virus in transplant recipients: Pearls from the guidelines and emerging frontiers

8:00 AM – 9:30 AM Room C4.8 Concurrent
Moderators: Wanessa T. Clemente (BR), Jeremy Chapman (AU)
- Pearls from the BK guidelines
  
  Nassim Kamar (FR)
- Pearls from the CMV guidelines
  
  Camille N. Kotton (US)
- Beyond the guidelines- new developments and future directions: BK
  
  Germaine Wong (AU)
- Beyond the guidelines - new developments and future directions: CMV
  
  Atul Humar (CA)
- Panel discussion: challenging BK case, challenging CMV case
  
  Discussion Period (AU)

TTS Business Meeting

12:00 PM – 12:30 PM Room Darling Harbour Plenary Session

No lectures listed yet.

Lunch Break / Industry Symposia / Lunch with Experts & Mentors

Industry Symposium

12:45 PM – 1:45 PM Room Parkside 1&2 Industry Symposium

No lectures listed yet.

Lunch and Learn Roundtable

12:45 PM – 1:30 PM Room The Gallery Experts/Mentors
- Combined liver–kidney transplantation
  
  Gomathy Narasimhan (IN)
- Designing and strengthening organ donation systems
  
  Marti Manyalich Vidal (ES)
- Genetic factors influencing transplant outcomes
  
  Stephen Alexander (AU)
- Clinical Trials in Kidney Transplantation
  
  Steve J. Chadban (AU)
- From HLA typing to epitope matching
  
  Lucy Sullivan (AU)
- Encouraging physical activity in transplant recipients with limited endurance or physical limitations
  
  Liz Schick (CH)
- Roundtable Mentor
  
  Roslyn B. Mannon (US)
- Roundtable Mentor
  
  Germaine Wong (AU)
- Roundtable Mentor
  
  Kate Wyburn (AU)
- Roundtable Mentor
  
  Medhat Askar (QA)
- Roundtable Mentor
  
  Macey L. Levan (US)
- Roundtable Mentor
  
  Henry Pleass (AU)
- TBD related to Uterus Transplant (ethics or donor/recipient selection or pregnancy challenge, etc)
  
  Mats Brännström (SE)
- Multi-Organ transplantation in children
  
  Tomoaki Kato (US)

SOTA, Thematic and Concurrent Sessions

Next-Generation Transplantation: Regenerative Medicine Breakthroughs

1:45 PM – 3:15 PM Room C4.8 SOTA/Thematic Session
Moderator: Giuseppe Orlando (US)
- The bioartificial kidney: Lessons learned and the road ahead
  
  William Fissell (CA)
- Organoids, organs-on-a-chip, and the path to organ manufacturing
  
  Sean Vincent Murphy (US)
- Artificial heart: A life-saving bridge to transplant
  
  Francisco Arabia (US)

Targeted Therapies and Tailored Dosing: The New Era in ABMR Treatment

1:45 PM – 3:15 PM Room C3.3 SOTA/Thematic Session
Moderator: Jen Li (AU)
- Is there still a role for anti IL-6R in ABMR treatment?
  
  Roslyn B. Mannon (US)
- Is anti-CD38 the most promising agent for ABMR?
  
  Katharina Mayer (AT)
- What does monitoring AUC add compared to C-trough only?
  
  Teun van Gelder (NL)
- Model Informed precision dosing
  
  Anders Asberg (NO)

Clinical Xenotransplantation has Arrived!

1:45 PM – 3:15 PM Room Cockle Bay 1 SOTA/Thematic Session
- Understanding optimal genetic modification
  
  Peter Cowan (AU)
- Experience and immunosuppression for clinical xenotransplantation
  
  Raphael Meier (US)
- Molecular analysis in clinical xenotransplantation
  
  Carmen Lefaucheur (FR)
- Clinical xenotransplantation: A new era through the eyes of patients and families
  
  Macey L. Levan (US)

Rise of the Machines: Maximizing donor opportunities in Thoracic Transplantation

1:45 PM – 3:15 PM Room C4.6 SOTA/Thematic Session
Moderator: Pablo Sanchez (US)
- Debate 1: Pro normothermic regional perfusion
  
  Ashish S. Shah (US)
- Debate 1: Pro ex vivo machine perfusion
  
  Peter MacDonald (AU)
- Debate 2: Pro ex vivo perfusion
  
  Sandra Lindstedt Ingemansson (SE)
- Debate 2: Pro immediate transplant
  
  Gregory I. Snell (AU)
- Expanding the donor pool: Practical implementation of normothermic regional perfusion for DCD heart and lung recovery
  
  Irene Bello Rodriguez (ES)
- Panel Discussion
  
  Discussion Period (AU)

State of VCA- Present and Future

1:45 PM – 3:15 PM Room C4.7 SOTA/Thematic Session
Moderators: Patrik Lassus (FI), Hatem Amer (US)
- Overview of VCA transplants
  
  Hatem Amer (US)
- VCA becoming part of universal health care
  
  David Leonard (GB)
- Is VCA reconstructive surgery or transplantation
  
  Linda C. Cendales (US)
- Challenges and opportunities for VCA in the global south
  
  Subramania Iyer (IN)
- Standardizing outcomes in VCA: Are we ready for a SONG or for COVER
  
  Allison Jaure (AU)

Evolving Ethics and Emerging Trends in Transplantation

1:45 PM – 3:15 PM Room C4.1 SOTA/Thematic Session
Moderators: David Thomson (ZA), Aviva Goldberg (CA)
- Rating ourselves on the ethics of NRP - How are we doing?
  
  Anji Wall (US)
- Social media use in transplantation
  
  Shaifali Sandal (CA)
- Ethical tissue sourcing for organoids: Why and How
  
  Katrina Bramstedt (CH)
- Pediatric prioritization
  
  Thozama Siyotula (ZA)
- Retransplantation after nonadherence (adult & children)
  
  Aaron Wightman (US)

Evolving strategies in intestinal and multivisceral transplantation

1:45 PM – 3:15 PM Room C4.9 SOTA/Thematic Session
Moderators: Helen Evans (NZ), Rajith Amaratunga (AU)
- Isolated intestine transplantation for short gut syndrome in the era of GLP-2 agonist
  
  Yaron Avitzur (CA)
- Novel immunosuppression in intestine transplantation
  
  Jennifer Garcia (US)
- Pros and cons of protocol biopsy and stoma
  
  Jonathan Hind (AU)

Diversity, Equity, and Inclusion in Gender and Transplantation

1:45 PM – 3:15 PM Room C3.6 SOTA/Thematic Session
- Regional and gender disparities in abstracts presented at international transplant congress
  
  Maggie Kam Man Ma (HK)
- Unseen and unequal: Addressing gender and financial disparities in access to kidney transplantation
  
  Elmi Muller (ZA)
- Redefining equity: Women, access, and outcomes in liver transplantation
  
  Gomathy Narasimhan (IN)
- Designing gender-responsive transplant policies: Lessons from south and southeast Asia
  
  Yeong Hoon Kim (KR)

Living Organ Donation in 2026: Unified Principles, Organ-Specific Nuances

1:45 PM – 3:15 PM Room Cockle Bay 2 SOTA/Thematic Session
- Shared framework for living donor evaluation: medical, psychosocial, and ethical core
  
  Krista Lentine (US)
- Surgical challenges and functional outcomes in living kidney donation
  
  Mireia Musquera (ES)
- Surgical challenges and functional outcomes in living liver donation
  
  DongJin Joo (KR)
- Predictive models and global registry insights to enhance donor safety
  
  Allan Massie (US)

Innovations in skin cancer in transplantation

1:45 PM – 3:15 PM Room C4.5 SOTA/Thematic Session
Moderators: Angela Webster (AU), Brenda Maria Rosales (AU)
- Skin cancer risk prediction and communication
  
  Anne Cust (AU)
- Evaluation of benefits and harms of melanoma screening in chronic disease
  
  Katy Bell (AU)
- Complex surgical oncology
  
  Alexander Varey (AU)
- Novel developments in keratinocyte cancer treatments in Australia
  
  Kiarash Khosrotehrani (AU)
- Panel Discussion
  
  Discussion Period (AU)

Pediatric cholestatic liver disease around the world

1:45 PM – 3:15 PM Room C3.4-C3.5 Concurrent
Moderator: Gabriel E. Gondolesi (US)
- Biliary atresia - whats happening in Latin America. Access to KPE and transplantation
  
  Monserrat Arreola Gutierrez (MX)
- Progressive familiar intrahepatic cholestasis differences around the world and the role of medical vs. surgical therapy
  
  Mohamed Rela (IN)
- Primary sclerosing cholangiotis in children and adolescent
  
  Michael Stormon (AU)

Organ donation following MAID (VAD/euthanasia)

1:45 PM – 3:15 PM Room C4.11 Concurrent
Moderator: Helen Opdam (AU)
- Panelist representing Canada
  
  Matthew Weiss (CA)
- Panelist representing Australia
  
  Wade Stedman (AU)

Closing Plenary

Closing Plenary

3:20 PM – 4:30 PM Room Darling Harbour Plenary Session
- Gene and cell therapy in transplantation
  
  Maria Grazia Roncarolo (US)
- From donor to recipient: Microbiome signatures as predictors of post-transplant complications
  
  Olivia Smibert (AU)